Metropolitan Bank Holding Corp. (MCB) SEC Filings & Earnings Calls
EquiReason read 20 Metropolitan Bank Holding Corp. SEC filings in the last 12 months. Latest: 8-K on 2026-10-20 — Metropolitan Bank reported Q3 2026 net income of $32.4M ($2.58/diluted share) vs $7.1M ($0.67) a year ago; net interest margin expanded to 4.36% from 3.88%; loan growth of 2.8% QoQ.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 1.2B
- P/E TTM
- 14.0
- Dividend yield
- 0.3%
- 52-week
- —
- Next earnings
- 18 Jan, in 86 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
20 Oct 20268-K · 2.02, 7.01Metropolitan Bank reported Q3 2026 net income of $32.4M ($2.58/diluted share) vs $7.1M ($0.67) a year ago; net interest margin expanded to 4.36% from 3.88%; loan growth of 2.8% QoQ; deposit growth of 7.6% QoQ; dividend declared $0.40/share.earningsopen
Figures in the filing · each found in the filing text
| Net income · Q3-2026 | $32M | +356% y/y |
| Diluted EPS · Q3-2026 | $2.58 | +285% y/y |
| Net interest income · Q3-2026 | $98M | +26% y/y |
| Net interest margin · Q3-2026 | 4.4% | |
| Total loans · 2026-09-30 | $7.50B | +11% y/y |
| Total deposits · 2026-09-30 | $8.30B | +18% y/y |
| Return on average assets · Q3-2026 | 1.4% | |
| Return on average equity · Q3-2026 | 13.1% | |
| Return on average tangible common equity · Q3-2026 | 13.2% | |
| Total risk-based capital ratio (Company) · 2026-09-30 | 13.9% |
Risks flagged
CRE loan concentration remains high at 301.1% of total risk-based capital, though declining.
“Total non-owner-occupied CRE loans were 301.1% of total risk-based capital at September 30, 2026” · word for word
19 Oct 20268-K · 8.01Board declared a quarterly cash dividend of $0.40 per share, an increase of $0.05 from the prior $0.35 per share.open
Figures in the filing · each found in the filing text
| dividend per share · Q4-2026 | $0.40 | +14% y/y |
31 Jul 202610-QMetropolitan Bank reported Q2 2026 results with net income of $19.2 million, up 2.4% YoY, but with a significant increase in provision for credit losses and net charge-offs.earningsopen
Figures in the filing · each found in the filing text
| Net interest income · Q2-2026 | $90M | +23% y/y |
| Provision for credit losses · Q2-2026 | $13M | +109% y/y |
| Net income · Q2-2026 | $19M | +2% y/y |
| Total deposits · 2026-06-30 | $7.73B | |
| Total loans, net of deferred fees and costs · 2026-06-30 | $7.33B | |
| Allowance for credit losses · 2026-06-30 | $62M | |
| Net charge-offs · Q2-2026 | $34M | |
| Non-accrual loans · 2026-06-30 | $67M | |
| Total stockholders' equity · 2026-06-30 | $968M | |
| Earnings per share (diluted) · Q2-2026 | $1.54 | -13% y/y |
Risks flagged
Credit Quality Deterioration
“Net charge-offs for the three and six months ended June 30, 2026 were $34.2 million and $46.7 million, respectively.” · word for word
High Provision for Credit Losses
“Provision for credit losses $13,325”
Elevated Non-Accrual Loans
“Non-accrual loans $66,970”
21 Jul 20268-K · 2.02, 7.01Net income $19M (+2% y/y); Diluted EPS $1.54 (-12% y/y); Net interest income $90M (+23% y/y)earningsopen
Figures in the filing · each found in the filing text
| Net income · Q2-2026 | $19M | +2% y/y |
| Diluted EPS · Q2-2026 | $1.54 | -13% y/y |
| Net interest income · Q2-2026 | $90M | +23% y/y |
| Net interest margin · Q2-2026 | 4.1% | |
| Total loans · Q2-2026 | $7.30B | +11% y/y |
| Total deposits · Q2-2026 | $7.70B | +14% y/y |
| Provision for credit losses · Q2-2026 | $13M |
Risks flagged
Credit quality deterioration: $13.3M provision for credit losses on a single C&I loan in non-core portfolio, indicating potential weakness in underwriting or sector exposure.
“$13.3 million provision for credit losses driven primarily by a single commercial and industrial (“C&I”) loan in a non-core portfolio segment” · word for word
Non-recurring expense items: $3.3M of isolated non-interest expense items impacted earnings.
“$3.3 million of isolated non-interest expense items” · word for word
20 Jul 20268-K · 8.01Increased quarterly cash dividend by $0.10 to $0.35 per share, a 40% increase from prior $0.25.open
Figures in the filing · each found in the filing text
| Quarterly cash dividend per share · Q3-2026 | $0.35 | +40% y/y |
22 Jun 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen
Risks flagged
Repurchases subject to market conditions, regulatory requirements; program may be discontinued.
“The number of shares to be repurchased and the timing of repurchases, if any, will depend on several factors, including market conditions, prevailing share price, corporate and regulatory requirements, and other considerations. The Share Repurchase Program has no expiration date, may be discontinued or suspended at any time and does not obligate the Company ”
8 May 202610-QNet Interest Income $86M (+28% y/y); Net Income $31M (+92% y/y); Diluted EPS $2.92 (+101% y/y)open
Figures in the filing · each found in the filing text
| Net Interest Income · Consolidated · Q1-2026 | $86M | +28% y/y |
| Net Income · Consolidated · Q1-2026 | $31M | +92% y/y |
| Diluted EPS · Consolidated · Q1-2026 | $2.92 | +101% y/y |
| Total Loans · Consolidated · 2026-03-31 | $7.05B | |
| Total Deposits · Consolidated · 2026-03-31 | $7.74B | |
| Provision for Credit Losses · Consolidated · Q1-2026 | $-2M | |
| Allowance for Credit Losses · Consolidated · 2026-03-31 | $82M |
Risks flagged
Commercial Real Estate Concentration
“CRE loans $5.4B out of $7.0B total loans, with $26.1M non-accrual and $2.1M without ACL.”
Multi-Family Loan Risk
“Multi-family loans $42.6M non-accrual, $7.8M without ACL.”
Unrealized Losses on Securities Portfolio
“AFS securities have $58.9M gross unrealized losses; HTM securities have $45.3M unrecognized losses.”
21 Apr 20268-K · 2.02, 7.01Net income $31M (+92% y/y); Diluted EPS $2.92 (+101% y/y); Net interest income $86M (+28% y/y)earningsopen
Figures in the filing · each found in the filing text
| Net income · Q1-2026 | $31M | +92% y/y |
| Diluted EPS · Q1-2026 | $2.92 | +101% y/y |
| Net interest income · Q1-2026 | $86M | +28% y/y |
| Net interest margin · Q1-2026 | 4.1% | |
| Total loans · Q1-2026 | $7.00B | +11% y/y |
| Total deposits · Q1-2026 | $7.70B | +20% y/y |
| Return on average tangible common equity · Q1-2026 | 15.6% | |
| Loan production · Q1-2026 | $428M |
Risks flagged
No significant risks identified; strong capital and credit metrics.
“total risk-based capital ratios of 14.6% and 14.3%, respectively, at March 31, 2026, well above regulatory minimums” · word for word
20 Mar 2026DEF 14AProxy statement detailing 2025 compensation outcomes, governance changes, and significant compensation program redesign for 2026 in response to failed say-on-pay vote.open
Figures in the filing · each found in the filing text
| Net Income · FY2025 | $71M | +7% y/y |
| Diluted EPS · FY2025 | $6.62 | +12% y/y |
| Net Interest Income · FY2025 | $303M | +20% y/y |
| Total Loans · 2025-12-31 | $6.80B | +13% y/y |
| Total Deposits · 2025-12-31 | $7.40B | +23% y/y |
| Net Interest Margin · FY2025 | 3.9% | |
| Return on Average Tangible Common Equity (ROATCE) · FY2025 | 9.8% | |
| Adjusted ROATCE · FY2025 | 10.5% | |
| Total Risk-Based Capital Ratio (Company) · 2025-12-31 | 12.3% | |
| Non-Interest Expense · FY2025 | $176M | +1% y/y |
Risks flagged
Say-on-Pay vote failure signals governance risk
“At our 2025 annual meeting, our 'say-on-pay' proposal did not receive the support of a majority of votes cast, a result that was well below the 91.4% level of support we received in the prior year.” · word for word
Credit risk from loan growth and charge-offs
“Net charge offs of 6 bps or $3.7 million in 2025 (compared to 0 bps or $0.1 million in 2024)” · word for word
Regulatory and compliance costs from growth
“The Company's enterprise risk management framework was enhanced to support crossing the $10 billion asset threshold, including significant work on the Company's compliance management systems and risk governance framework.” · word for word
16 Mar 20268-K · 8.01Metropolitan Bank Holding Corp. issued 213,395 shares of common stock upon underwriters' exercise of option, raising net proceeds of approximately $17.2 million. Follow-on equity issuance, dilutive to existing shareholders.open
Figures in the filing · each found in the filing text
| Net proceeds · Q1-2026 | $17M |
Risks flagged
Dilution from additional share issuance; moderate impact given size relative to offering.
“Issuance of 213,395 shares of common stock.”
2 Mar 20268-K · 7.01Issued a Regulation FD disclosure (forward guidance or material update); filed financial statements and exhibits with this reportopen
Risks flagged
Standard risk factors; no new material risks identified.
“Forward-looking statements with standard risk factors.”
26 Feb 20268-K · 1.01, 7.01Metropolitan Bank Holding Corp. priced an underwritten public offering of 2,100,000 shares of common stock at $85.00 per share, expecting net proceeds of ~$169.3 million for organic growth and general corporate purposes.open
Figures in the filing · each found in the filing text
| Offering Shares · 2026-02-25 | 2,100,000 | |
| Offering Price per Share · 2026-02-25 | $85.00 | |
| Net Proceeds · 2026-02-25 | $169M |
Risks flagged
Dilution risk: 2.1M new shares issued; potential overhang if stock price declines.
“2,100,000 shares of common stock”
25 Feb 20268-K · 7.01Offering amount $175Mopen
Figures in the filing · each found in the filing text
| offering amount · Q1-2026 | $175M |
Risks flagged
Dilution risk from new equity issuance
“offering of $175 million common stock, with option for additional 15%”
20 Feb 202610-KTotal assets $8.30B; Total loans $6.80B; Total deposits $7.40Bopen
Figures in the filing · each found in the filing text
| Total assets · FY2025 | $8.30B | |
| Total loans · FY2025 | $6.80B | |
| Total deposits · FY2025 | $7.40B | |
| Stockholders' equity · FY2025 | $743M | |
| CRE and C&I loans as % of total loans · FY2025 | 98.6% | |
| Healthcare real estate loans · FY2025 | $2.50B | |
| NYC rent-regulated multi-family loans · FY2025 | $173M | |
| AFS securities amortized cost · FY2025 | $633M | |
| AFS securities fair value · FY2025 | $579M | |
| Accumulated other comprehensive loss · FY2025 | $40M |
Risks flagged
High CRE concentration risk
“At December 31, 2025, $6.7 billion, or 98.6% of total loans, consisted of CRE and C&I loans.” · word for word
Rent regulation risk on multi-family loans
“At December 31, 2025, the Company had $172.6 million of New York City rent-regulated stabilized multi-family loans, which had a weighted-average debt service coverage ratio of 2.7x and a weighted-average LTV of 44.7% based on the most recent appraisal.” · word for word
Interest rate risk from AFS securities
“At December 31, 2025, we reported an accumulated other comprehensive loss of $39.7 million, net of tax, related to net changes in unrealized losses in the AFS securities portfolio, which negatively impacted stockholders’ equity, as well as book value per common share.” · word for word
20 Jan 20268-K · 2.02, 7.01Net income $29M (+35% y/y); Diluted earnings per share $2.77 (+47% y/y); Net interest margin 4.1earningsopen
Figures in the filing · each found in the filing text
| Net income · Q4-2025 | $29M | +35% y/y |
| Diluted earnings per share · Q4-2025 | $2.77 | +47% y/y |
| Net interest margin · Q4-2025 | 4.1% | |
| Return on average equity (annualized) · Q4-2025 | 15.6% | |
| Return on average tangible common equity (annualized) · Q4-2025 | 15.8% | |
| Total loans · Q4-2025 | $6.80B | +13% y/y |
| Total deposits · Q4-2025 | $7.40B | +23% y/y |
| Net interest income · Q4-2025 | $85M | +28% y/y |
| Total revenues · Q4-2025 | $88M | +25% y/y |
| Loan production · Q4-2025 | $511M | +65% y/y |
Risks flagged
CRE concentration ratio increased to 376.5% of total risk-based capital; regulatory scrutiny risk.
“Total non-owner-occupied CRE loans were 376.5% of total risk-based capital at December 31, 2025, compared to 373.5% and 346.1% at September 30, 2025 and December 31, 2024, respectively.” · word for word
C&I loans decreased $81.4M QoQ and $174.5M YoY; potential shift in loan mix.
“partially offset by a decrease of $81.4 million in commercial and industrial (“C&I”) loans” · word for word
16 Jan 20268-K · 8.01Quarterly cash dividend per share $0.20 (+33% y/y)open
Figures in the filing · each found in the filing text
| Quarterly cash dividend per share · Q1-2026 | $0.20 | +33% y/y |
7 Nov 202510-QNet income fell 42% YoY due to a 787% surge in provision for credit losses from multi-family CRE deterioration, despite strong loan growth and NII expansion.earningsopen
Figures in the filing · each found in the filing text
| Net income · Q3-2025 | $7M | -42% y/y |
| Net interest income · Q3-2025 | $77M | +19% y/y |
| Provision for credit losses · Q3-2025 | $24M | +787% y/y |
| Total loans · Q3-2025 | $6.78B | |
| Total deposits · Q3-2025 | $7.07B | |
| Earnings per share (basic) · Q3-2025 | $0.68 | -38% y/y |
| Allowance for credit losses · Q3-2025 | $94M |
Risks flagged
Multi-family CRE credit deterioration
“Provision for credit losses 23,862 2,691 34,746 4,757” · word for word
Elevated nonperforming loans
“Non-accrual loans $81.6M vs $32.5M at Dec 2024”
Metropolitan Bank Holding Corp. — questions
- What did Metropolitan Bank Holding Corp. file recently?
- 20 SEC filings in the last 12 months. Latest: 8-K on 2026-10-20 — Metropolitan Bank reported Q3 2026 net income of $32.4M ($2.58/diluted share) vs $7.1M ($0.67) a year ago; net interest margin expanded to 4.36% from 3.88%; loan growth of 2.8% QoQ; deposit growth of 7.6% QoQ; dividend declared $0.40/share.
Every figure on this page comes from Metropolitan Bank Holding Corp.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.